Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis

Figure 7

Relationship between IGF2BP3 expression and immune therapy. (a) PD-1 expression levels; (b) PD-L1 expression levels; (c) CTLA-4 expression levels; (d) response to immune checkpoint blockade therapy.

(a)

(b)

(c)

(d)